Also known as: acquired hemolytic anemia, autoimmune hemolytic anemia, extrinsic hemolytic anemia, intrinsic hemolytic anemia
What is hemolytic anemia?
Anemia is a disorder in which the body doesn’t have enough red blood cells. Hemolysis is a method whereby red blood cells are broken down and destroyed. There are are large number of different ways this can happen and therefore there are a large number of types of hemolytic anemia. As red cells are broken down, the bone marrow has to produce more new ones, faster. Depending on how fast (acute hemolytic anemia) or slowly (chronic hemolytic anemia) the red cells are destroyed (and the bone marrow attempts to replace them) so the signs/symptoms and complication will vary.
What causes hemolytic anemia?
In general, one can divide hemolytic anemias into those causes that infants/children a born with from an abnormality of the red cell wall (Intrinsic- congenital hemolytic anemias- e.g. Sickle cell anemia etc) and those that are caused after birth from a multitude of different factors outside the cell (Extrinsic- infection, medicines, cancers, autoimmune disorders etc).
What are the signs/symptoms of hemolytic anemia?
Depending whether the hemolysis is acute or chronic, signs/symptoms will vary from minimal, to pale skin, dark urine, yellow eyes/skin, a large liver and spleen and symptoms of anemia like weakness, dizziness, fatigue, and a fast heartbeat.
What are hemolytic anemia care options?
Depending on the underlying cause, treatment options may include blood and/or exchange transfusions, corticosteroids, immunosuppressive therapy, erythropoietin, other medications and splenectomy.
Reviewed by: Jack Wolfsdorf, MD, FAAP
This page was last updated on: 5/23/2018 2:33:14 PM
Camp U.O.T.S. is an annual weeklong, overnight camp for children with cancer and blood disorders who are treated at Nicklaus Children’s Hospital.
Learn more and register
From the Newsdesk
More than two dozen children attended the Bear Hug camp at Nicklaus Children's last week. This day camp is for siblings of pediatric cancer patients to encourage socialization among peers and help them gain insight on their siblings' care journey.
On this very same day nine years ago, Daniella Alvarez was diagnosed Teratoid Rhabdoid Tumor (ATRT), a rare and aggressive type of brain cancer. The news came on June 26, 2009, her second birthday. Daniella endured years of brain surgeries, aggressive chemotherapies, radiation, imaging scans, multiple visits to intensive care at Nicklaus Children’s Hospital. She is now cancer free thanks to a pediatric clinical trial made possible through research funding.